Endo Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference

CHADDS FORD, Pa., June 1, 2011 /PRNewswire/ — Endo
Pharmaceuticals (Nasdaq:
ENDP) today announced that Alan Levin, executive vice president
and chief financial officer will present a corporate overview at
the Goldman Sachs Global Healthcare Conference on Wednesday, June
8, 2011 at 1:20 p.m. PT.  The conference will be held at the
Terranea Resort in Rancho Palos Verdes, CA.

A live webcast and audio archive of the presentation will be
available on the company’s website at http://www.endo.com/.  Click
on Investor Relations, and then the link to the Event and
Presentation.  Participants should allow approximately ten
minutes prior to the presentation’s start time to visit the site
and download any streaming media software needed to listen to the
Internet webcast.

About Endo

Endo Pharmaceuticals is a U.S.-based, specialty healthcare
solutions company, focused on high-value branded products and
specialty generics. Endo is redefining its position in the
healthcare marketplace by anticipating and embracing the evolution
of health decisions based on the need for high-quality and
cost-effective care. We aim to be the premier partner to healthcare
professionals and payment providers, delivering an innovative suite
of complementary diagnostics, drugs, devices and clinical data to
meet the needs of patients in areas such as pain, urology, oncology
and endocrinology. For more information about Endo Pharmaceuticals,
and its wholly owned subsidiaries HealthTronics, Inc. and Qualitest
Pharmaceuticals, please visit http://www.endo.com/.

‘/>”/>

SOURCE